# Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo

Study · id `cardio:ct-nct01999829` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01999829](<https://clinicaltrials.gov/study/NCT01999829>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01999829

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT01999829. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT01999829, source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT01999829, source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)
- Primary completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01999829, source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)
- Completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01999829, source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT01999829, source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01999829-2017-03-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo
- Condition: Atrial Fibrillation
- Intervention (Drug): citrate of caffeine
- Intervention (Drug): placebo
- Lead sponsor: Assistance Publique Hopitaux De Marseille
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Assistance Publique Hopitaux De Marseille (`cardio:org-assistance-publique-hopitaux-de-marseille`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: A randomised controlled clinical trial (`cardio:pubmed-29702502`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5a17b04f8542532a84cba7ba1c9c6b31f6263149ec79d2f2e34f95dde1c31152
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
